Here’s why Sarepta invested in a departing exec’s new startup

One of Sarepta Therapeutics' longtime executives, Alexander “Bo” Cumbo, is leaving the company to launch a new gene therapy company — and his former employer is getting involved.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.